EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
44 hedge funds and large institutions have $8.59M invested in Evofem Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 34
Holders
44
Holding in Top 10
–
Calls
$3.83M
Puts
$1.18M
Top Buyers
| 1 | +$2.92M | |
| 2 | +$2.2M | |
| 3 | +$990K | |
| 4 |
Citigroup
New York
|
+$832K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$215K |
Top Sellers
| 1 | -$955K | |
| 2 | -$230K | |
| 3 | -$167K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$135K |
| 5 |
JCP
JB Capital Partners
Armonk,
New York
|
-$118K |